Implications of Facebook's Page Commenting Changes

Broadcast in Business

Call in to speak with the host

(347) 996-5894

h:755
s:1772005
archived
Pharmaguy

Pharmaguy

×  

Follow This Show

If you liked this show, you should follow Pharmaguy.

Interview of Matt Snodgrass, Social Media Director at WCG, about Facebook's planned changes to its "whitelisting" policy and its implications for pharmaceutical marketers.

Comments

 comments